Furthermore, this is the first attempt to demonstrate enzyme kinetics and simulate molecular docking of 1–3 against these two enzymes, and demonstrate glucose uptake activity in insulin-resistant HepG2 cells which is worthwhile to explore the pharmacological mechanism of M. alba in type II diabetes. Here, INS is linked to type 2 diabetes mellitus.